Reports

Ideas That Generate Results

List of Figures:

Figure 4-1: Global - Venture Capitalist Investments in Gene Threapy Product Development (Billion US$), 1999 to H1 2015
Figure 5-1: Global - Number of Approved Gene Therapy Clinical Trials (2005-July 2015)
Figure 5-2: Global - Geographical Distribution of Gene Therapy Clinical Trials by Continents till July, 2015
Figure 5-3: Global - Geographical Distribution of Gene Therapy Clinical Trials by Countries till July, 2015
Figure 5-4: Global - Gene Therapy Clinical Trials by Indication till July, 2015
Figure 5-5: Global - Gene Therapy Clinical Trials by Types of Gene Transferred till July, 2015
Figure 5-6: Global - Gene Therapy Clinical Trials by Percentage of Vectors Used till July, 2015
Figure 5-7: Global - Gene Therapy Clinical Trials by Phase till July, 2015
Figure 6-1: US - Number of New Cell Therapy and Gene Therapy Products Submission to FDA (2003-2010)
Figure 6-2: Japan - Evaluation System of Gene Therapy Clinical Trial
Figure 7-1: Global - Neovasculgen Sales (Million US$), 2013 & 2014
Figure 8-1: Global - Gene Therapy Market (Million US$), 2014, 2015 & 2020
Figure 9-1: Global - Gene Therapy Market by Application (%), 2015
Figure 9-2: Global - Gene Therapy Market by Application (%), 2020
Figure 9-3: Global - Gene Therapy Oncology Market (Million US$), 2014, 2015 & 2020
Figure 9-4: Global - Gene Therapy Oncology Market by Geography (%), 2015
Figure 9-5: Global - Gene Therapy Cardiovascular Disease Market (Million US$), 2014, 2015 & 2020
Figure 9-6: Global - Gene Therapy Cardiovascular Disease Market by Geography (%), 2015
Figure 9-7: Global - Gene Therapy Infectious Disease Market (Million US$), 2014, 2015 & 2020
Figure 9-8: Global - Gene Therapy Infectious Disease Market by Geography (%), 2015
Figure 9-9: Global - Gene Therapy Neurological Disease Market (Million US$), 2014, 2015 & 2020
Figure 9-10: Global - Gene Therapy Neurological Disease Market by Geography (%), 2015
Figure 9-11: Global - Gene Therapy Genetic Disease Market (Million US$), 2014, 2015 & 2020
Figure 9-12: Global - Gene Therapy Genetic Disease Market, by Geography (%), 2015
Figure 9-13: Global - Gene Therapy Other Disease Market (Million US$), 2014, 2015 & 2020
Figure 9-14: Global - Gene Therapy Other Disease Market by Geography (%), 2015
Figure 10-1: Global - Gene Therapy Market by Geography (%), 2015
Figure 10-2: North America - Gene Therapy Market (Million US$), 2014, 2015 & 2020
Figure 10-3: Europe - Gene Therapy Market (Million US$), 2014, 2015 & 2020
Figure 10-4: Asia - Gene Therapy Market (Million US$), 2014, 2015 & 2020
Figure 10-5: Asia - Number of Gene Therapy Laboratories by Major Asian Countries (2014)
Figure 10-6: India - Number of Gene Therapy Laboratories (2000, 2010 & 2013)
Figure 10-7: Rest of the World - Gene Therapy Market (Million US$), 2014, 2015 & 2020
Figure 11-1: Key Growth Strategies Adopted by Key Players (2013 to 2015)
Figure 11-2: Key Players Focusing on Strategic Collaborations (2013 to 2015)
Figure 11-3: Key Players Focusing on Strategic Acquisitions (2013 to 2015)
Figure 11-4: Key Players Focusing on Funding & Investments (2013 to 2015)
Figure 11-5: Companies Progress in Gene Therapy till 2015

List of Tables:

Table 4-1: US - Gene Therapies under Development
Table 4-2: Europe - Gene Therapies under Development
Table 4-3: Gene Therapy Companies Funded by Venture Capital Firms
Table 4-4: Current Status of Clinical Trials for Hemophilia
Table 5-1: Human Gene Transfer Trials Approved by Condition till 2012
Table 5-2: Key Ongoing Gene Therapy Clinical Trials
Table 6-1: China - Key Players and their Products in Gene Therapy
Table 9-1: Vectors Used for Cardiovascular Gene Transfer
Table 12-1: Spark Therapeutics LLC - Clinical Pipeline in Gene Therapy
Table 12-2: ViroMed Co. Ltd. - Clinical Pipeline in Gene Therapy
Table 12-3: Advantagene Inc. - Clinical Pipeline in Gene Therapy
Table 12-4: Bluebird Bio - Clinical Pipeline in Gene Therapy
Table 12-5: Sanofi - Clinical Pipeline in Gene Therapy
Table 12-6: Vical Inc. - Clinical Pipeline in Gene Therapy
Table 12-7: Oxford Biomedica Plc - Clinical Pipeline in Gene Therapy
Table 12-8: Genethon - Clinical Pipeline in Gene Therapy
Table 12-9: UniQure N.V. - Clinical Pipeline in Gene Therapy
Table 12-10: Human Stem Cells Institute - Clinical Pipeline in Gene Therapy
Table 12-11: Shanghai Sunway Biotech Co. Ltd. - Clinical Pipeline in Gene Therapy
Table 12-12: Sibiono GeneTech Co. Ltd. - Clinical Pipeline in Gene Therapy